IMpower133: Is there Finally a New Standard of Care for Extensive Stage SCLC? (BMIC-064)
Nov 06, 2018•8 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Dr. Jack West reviews the IMpower133 trial that integrated atezolizumab with first line chemo for extensive stage SCLC and discusses whether the results improve outcomes enough to change our standard of care in this setting.
For the best experience, listen in Metacast app for iOS or Android
Open in Metacast